AAAAAA
Results: 1-25/28
Authors:
Middleton, RJ
Parfrey, PS
Foley, RN
Citation: Rj. Middleton et al., Left ventricular hypertrophy in the renal patient, J AM S NEPH, 12(5), 2001, pp. 1079-1084
Authors:
Parfrey, PS
Citation: Ps. Parfrey, Is renal insufficiency an atherogenic state? Reflections on prevalence, incidence, and risk, AM J KIDNEY, 37(1), 2001, pp. 154-156
Authors:
Hutchinson, JM
Jelinski, S
Hefferton, D
Desaulniers, G
Parfrey, PS
Citation: Jm. Hutchinson et al., Role of diagnostic labeling in antibiotic prescription, CAN FAM PHY, 47, 2001, pp. 1217-1224
Authors:
Beales, PL
Katsanis, N
Lewis, RA
Ansley, SJ
Elcioglu, N
Raza, J
Woods, MO
Green, JS
Parfrey, PS
Davidson, WS
Lupski, JR
Citation: Pl. Beales et al., Genetic and mutational analyses of a large multiethnic Bardet-Biedl cohortreveal a minor involvement of BBS6 and delineate the critical intervals ofother loci, AM J HU GEN, 68(3), 2001, pp. 606-616
Authors:
Slavotinek, AM
Stone, EM
Mykytyn, K
Heckenlively, JR
Green, JS
Heon, E
Musarella, MA
Parfrey, PS
Sheffield, VC
Biesecker, LG
Citation: Am. Slavotinek et al., Mutations in MKKS cause Bardet-Biedl syndrome, NAT GENET, 26(1), 2000, pp. 15-16
Authors:
Katsanis, N
Beales, PL
Woods, MO
Lewis, RA
Green, JS
Parfrey, PS
Ansley, SJ
Davidson, WS
Lupski, JR
Citation: N. Katsanis et al., Mutations in MKKS cause obesity, retinal dystrophy and renal malformationsassociated with Bardet-Biedl syndrome, NAT GENET, 26(1), 2000, pp. 67-70
Authors:
Foley, RN
Parfrey, PS
Kent, GM
Harnett, JD
Murray, DC
Barre, PE
Citation: Rn. Foley et al., Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease, J AM S NEPH, 11(5), 2000, pp. 912-916
Authors:
Murphy, SW
Barrett, BJ
Parfrey, PS
Citation: Sw. Murphy et al., Contrast nephropathy, J AM S NEPH, 11(1), 2000, pp. 177-182
Authors:
Parfrey, PS
Citation: Ps. Parfrey, Cardiac disease in dialysis patients: diagnosis, burden of disease, prognosis, risk factors and management, NEPH DIAL T, 15, 2000, pp. 58-68
Authors:
Bianchi, G
London, GM
Marcelli, D
Massy, ZA
Parfrey, PS
Passlick-Deetjen, J
Rabelink, TJ
Wanner, C
Citation: G. Bianchi et al., Clinical algorithms on cardiovascular risk factors in renal patients, NEPH DIAL T, 15, 2000, pp. 123
Authors:
Rigatto, C
Parfrey, PS
Citation: C. Rigatto et Ps. Parfrey, Homocysteine and cardiovascular risk in dialysis patients, PERIT DIA I, 20(2), 2000, pp. 167-168
Authors:
Murphy, ST
Parfrey, PS
Citation: St. Murphy et Ps. Parfrey, The impact of anemia correction on cardiovascular disease in end-stage renal disease, SEM NEPHROL, 20(4), 2000, pp. 350-355
Authors:
Foley, RN
Parfrey, PS
Morgan, J
Barre, PE
Campbell, P
Cartier, P
Coyle, D
Fine, A
Handa, P
Kingma, I
Lau, CY
Levin, A
Mendelssohn, D
Muirhead, N
Murphy, B
Plante, RK
Posen, G
Wells, GA
Citation: Rn. Foley et al., Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy, KIDNEY INT, 58(3), 2000, pp. 1325-1335
Authors:
Murphy, SW
Foley, RN
Barrett, BJ
Kent, GM
Morgan, J
Barre, P
Campbell, P
Fine, A
Goldstein, MB
Handa, SP
Jindal, KK
Levin, A
Mandin, H
Muirhead, N
Richardson, RMA
Parfrey, PS
Citation: Sw. Murphy et al., Comparative hospitalization of hemodialysis and peritoneal dialysis patients in Canada, KIDNEY INT, 57(6), 2000, pp. 2557-2563
Authors:
Murphy, SW
Foley, RN
Barrett, BJ
Kent, GM
Morgan, J
Barre, P
Campbell, P
Fine, A
Goldstein, MB
Handa, SP
Jindal, KK
Levin, A
Mandin, H
Muirhead, N
Richardson, RMA
Parfrey, PS
Citation: Sw. Murphy et al., Comparative mortality of hemodialysis and peritoneal dialysis in Canada, KIDNEY INT, 57(4), 2000, pp. 1720-1726
Authors:
Rigatto, C
Foley, RN
Kent, GM
Guttmann, R
Parfrey, PS
Citation: C. Rigatto et al., Long-term changes in left ventricular hypertrophy after renal transplantation, TRANSPLANT, 70(4), 2000, pp. 570-575
Authors:
Culleton, BF
Larson, MG
Parfrey, PS
Kannel, WB
Levy, D
Citation: Bf. Culleton et al., Proteinuria as a risk factor for cardiovascular disease and mortality in older people: A prospective study, AM J MED, 109(1), 2000, pp. 1-8
Authors:
Murphy, ST
Parfrey, PS
Citation: St. Murphy et Ps. Parfrey, Erythropoietin therapy in chronic uremia: the impact of normalization of hematocrit, CURR OP NEP, 8(5), 1999, pp. 573-578
Authors:
Parfrey, PS
Foley, RN
Citation: Ps. Parfrey et Rn. Foley, The clinical epidemiology of cardiac disease in chronic renal failure, J AM S NEPH, 10(7), 1999, pp. 1606-1615
Authors:
Parfrey, PS
Citation: Ps. Parfrey, Cardiac disease in dialysis patients - Introduction, SEMIN DIAL, 12(2), 1999, pp. 61-61
Authors:
Parfrey, PS
Citation: Ps. Parfrey, Pathogenesis of cardiac disease in dialysis patients, SEMIN DIAL, 12(2), 1999, pp. 62-68
Authors:
Foley, RN
Parfrey, PS
Citation: Rn. Foley et Ps. Parfrey, Anemia as a risk factor for cardiac disease in dialysis patients, SEMIN DIAL, 12(2), 1999, pp. 84-86
Authors:
Woods, MO
Young, TL
Parfrey, PS
Hefferton, D
Green, JS
Davidson, WS
Citation: Mo. Woods et al., Genetic heterogeneity of Bardet-Biedl syndrome in a distinct Canadian population: Evidence for a fifth locus, GENOMICS, 55(1), 1999, pp. 2-9
Authors:
Culleton, BF
Larson, MG
Wilson, PWF
Evans, JC
Parfrey, PS
Levy, D
Citation: Bf. Culleton et al., Cardiovascular disease and mortality in a community-based cohort with mildrenal insufficiency, KIDNEY INT, 56(6), 1999, pp. 2214-2219
Authors:
Parfrey, PS
Foley, RN
Rigatto, C
Citation: Ps. Parfrey et al., Risk issues in renal transplantation: Cardiac aspects, TRANSPLAN P, 31(1-2), 1999, pp. 291-293